Your browser doesn't support javascript.
loading
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern.
Gonzalez-Rodriguez, Edgar; Zol-Hanlon, Mia; Bineva-Todd, Ganka; Marchesi, Andrea; Skehel, Mark; Mahoney, Keira E; Roustan, Chloë; Borg, Annabel; Di Vagno, Lucia; Kjær, Svend; Wrobel, Antoni G; Benton, Donald J; Nawrath, Philipp; Flitsch, Sabine L; Joshi, Dhira; González-Ramírez, Andrés Manuel; Wilkinson, Katalin A; Wilkinson, Robert J; Wall, Emma C; Hurtado-Guerrero, Ramón; Malaker, Stacy A; Schumann, Benjamin.
Afiliação
  • Gonzalez-Rodriguez E; Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Zol-Hanlon M; Department of Chemistry, Imperial College London, W12 0BZ London, United Kingdom.
  • Bineva-Todd G; Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Marchesi A; Signalling and Structural Biology Lab, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Skehel M; Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Mahoney KE; Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Roustan C; Department of Chemistry, Imperial College London, W12 0BZ London, United Kingdom.
  • Borg A; Proteomics Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Di Vagno L; Department of Chemistry, Yale University, 275 Prospect Street, 06511 New Haven, Connecticut, United States.
  • Kjær S; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Wrobel AG; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Benton DJ; Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Nawrath P; Proteomics Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Flitsch SL; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Joshi D; Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT London, United Kingdom.
  • González-Ramírez AM; Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Wilkinson KA; Structural Biology of Disease Processes Laboratory, Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Wilkinson RJ; Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, M1 7DN Manchester, United Kingdom.
  • Wall EC; Chemical Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Hurtado-Guerrero R; Institute of Biocomputation and Physics of Complex Systems, University of Zaragoza, 50018 Zaragoza, Spain.
  • Malaker SA; Tuberculosis Laboratory, The Francis Crick Institute, NW1 1AT London, United Kingdom.
  • Schumann B; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, 7925 Observatory, Cape Town, South Africa.
ACS Cent Sci ; 9(3): 393-404, 2023 Mar 22.
Article em En | MEDLINE | ID: mdl-36968546
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: ACS Cent Sci Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: ACS Cent Sci Ano de publicação: 2023 Tipo de documento: Article